{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:42:16Z","timestamp":1790682136258,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-22-CE15-0038-02"],"award-info":[{"award-number":["ANR-22-CE15-0038-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["PLBIO 2018-132"],"award-info":[{"award-number":["PLBIO 2018-132"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bbcan.2023.189004","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T06:54:02Z","timestamp":1697784842000},"page":"189004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways"],"prefix":"10.1016","volume":"1878","author":[{"given":"Layla","family":"Haymour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Smulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Legembre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(91)90614-5","article-title":"The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis","volume":"66","author":"Itoh","year":"1991","journal-title":"Cell"},{"issue":"5475","key":"10.1016\/j.bbcan.2023.189004_bb0010","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.288.5475.2354","article-title":"Fas Preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations","volume":"288","author":"Siegel","year":"2000","journal-title":"Science"},{"issue":"30","key":"10.1016\/j.bbcan.2023.189004_bb0015","doi-asserted-by":"crossref","first-page":"18827","DOI":"10.1074\/jbc.272.30.18827","article-title":"Characterization of Fas (Apo-1, CD95)-Fas ligand interaction","volume":"272","author":"Schneider","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bbcan.2023.189004_bb0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41419-022-05352-0","article-title":"MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways","volume":"13","author":"Kenji","year":"2022","journal-title":"Cell Death Dis."},{"issue":"20","key":"10.1016\/j.bbcan.2023.189004_bb0025","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1038\/sj.onc.1207387","article-title":"Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells","volume":"23","author":"Strand","year":"2004","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbcan.2023.189004_bb0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.molcel.2016.01.009","article-title":"Structural basis and functional role of intramembrane Trimerization of the Fas\/CD95 death receptor","volume":"61","author":"Fu","year":"2016","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.bbcan.2023.189004_bb0035","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1091\/mbc.e08-02-0161","article-title":"A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates Rac1 and controls neurite growth","volume":"19","author":"Ruan","year":"2008","journal-title":"Mol. Biol. Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2023.189004_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001090","article-title":"The naturally processed CD95L elicits a c-yes\/calcium\/PI3K-driven cell migration pathway","volume":"9","author":"Tauzin","year":"2011","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2016.06.028","article-title":"CD95-mediated calcium signaling promotes T helper 17 trafficking to inflamed organs in lupus-prone mice","volume":"45","author":"Poissonnier","year":"2016","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bbcan.2023.189004_bb0050","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41589-018-0162-9","article-title":"Disrupting the CD95-PLCgamma1 interaction prevents Th17-driven inflammation","volume":"14","author":"Poissonnier","year":"2018","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2023.189004_bb0055","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0968-0004(00)89070-2","article-title":"The death domain: a module shared by proteins with diverse cellular functions","volume":"20","author":"Feinstein","year":"1995","journal-title":"Trends Biochem. Sci."},{"issue":"5209","key":"10.1016\/j.bbcan.2023.189004_bb0060","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1126\/science.7536343","article-title":"FAP-1: a protein tyrosine phosphatase that associates with Fas","volume":"268","author":"Sato","year":"1995","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bbcan.2023.189004_bb0065","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1083\/jcb.201805071","article-title":"Cell polarity and adherens junction formation inhibit epithelial Fas cell death receptor signaling","volume":"217","author":"Gagnoux-Palacios","year":"2018","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2023.189004_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103538","article-title":"CD95\/Fas suppresses NF-kappaB activation through recruitment of KPC2 in a CD95L\/FasL-independent mechanism","volume":"24","author":"Guegan","year":"2021","journal-title":"iScience"},{"issue":"22","key":"10.1016\/j.bbcan.2023.189004_bb0075","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","article-title":"Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor","volume":"14","author":"Kischkel","year":"1995","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.molcel.2012.05.004","article-title":"A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death","volume":"47","author":"Dickens","year":"2012","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2023.189004_bb0085","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/febs.14292","article-title":"Nonapoptotic functions of Fas\/CD95 in the immune response","volume":"285","author":"Guegan","year":"2018","journal-title":"FEBS J."},{"issue":"22","key":"10.1016\/j.bbcan.2023.189004_bb0090","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.4161\/cc.10.22.18290","article-title":"How CD95 stimulates invasion","volume":"10","author":"Steller","year":"2011","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ncb916","article-title":"Fas engagement induces neurite growth through ERK activation and p35 upregulation","volume":"5","author":"Desbarats","year":"2003","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2023.189004_bb0100","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","article-title":"Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family","volume":"75","author":"Suda","year":"1993","journal-title":"Cell"},{"issue":"6712","key":"10.1016\/j.bbcan.2023.189004_bb0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/25387","article-title":"Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer","volume":"396","author":"Pitti","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2023.189004_bb0110","doi-asserted-by":"crossref","first-page":"1074099","DOI":"10.3389\/fimmu.2022.1074099","article-title":"Role of metalloproteases in the CD95 signaling pathways","volume":"13","author":"Devel","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0968-0004(01)01995-8","article-title":"The molecular architecture of the TNF superfamily","volume":"27","author":"Bodmer","year":"2002","journal-title":"Trends Biochem. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2023.189004_bb0120","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"issue":"5215","key":"10.1016\/j.bbcan.2023.189004_bb0125","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.bbcan.2023.189004_bb0130","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","author":"Motz","year":"2014","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2023.189004_bb0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm0498-415","article-title":"TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation","volume":"4","author":"Sata","year":"1998","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/labinvest.3780225","article-title":"Hypoxia stimulates release of the soluble form of fas ligand that inhibits endothelial cell apoptosis","volume":"81","author":"Mogi","year":"2001","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0145","first-page":"130","article-title":"The CD95\/CD95L signaling pathway: a role in carcinogenesis","volume":"1846","author":"Fouque","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0003-9861(02)00525-8","article-title":"Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand","volume":"408","author":"Vargo-Gogola","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.bbcan.2023.189004_bb0155","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/sj.cdd.4402175","article-title":"The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells","volume":"14","author":"Kirkin","year":"2007","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bbcan.2023.189004_bb0160","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/sj.cdd.4402101","article-title":"ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death","volume":"14","author":"Schulte","year":"2007","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.bbcan.2023.189004_bb0165","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","article-title":"Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity","volume":"187","author":"Schneider","year":"1998","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.bbcan.2023.189004_bb0170","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1084\/jem.186.12.2045","article-title":"Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing","volume":"186","author":"Suda","year":"1997","journal-title":"J. Exp. Med."},{"issue":"7264","key":"10.1016\/j.bbcan.2023.189004_bb0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nature08402","article-title":"Membrane-bound Fas ligand only is essential for Fas-induced apoptosis","volume":"461","author":"O\u2019 Reilly","year":"2009","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.bbcan.2023.189004_bb0180","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/sj.emboj.7600325","article-title":"CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells","volume":"23","author":"Barnhart","year":"2004","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.bbcan.2023.189004_bb0185","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1053\/j.gastro.2010.02.046","article-title":"Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells","volume":"138","author":"Hoogwater","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0190","first-page":"189","article-title":"CD95 signaling in colorectal cancer","volume":"1826","author":"Hoogwater","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bbcan.2023.189004_bb0195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ccr.2008.02.003","article-title":"Yes and PI3K bind CD95 to signal invasion of glioblastoma","volume":"13","author":"Kleber","year":"2008","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.bbcan.2023.189004_bb0200","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1158\/0008-5472.CAN-13-1794","article-title":"CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancer","volume":"73","author":"Malleter","year":"2013","journal-title":"Cancer Res."},{"issue":"5\u20136","key":"10.1016\/j.bbcan.2023.189004_bb0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10495-019-01540-0","article-title":"Modulation of CD95-mediated signaling by post-translational modifications: towards understanding CD95 signaling networks","volume":"24","author":"Seyrek","year":"2019","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188596","article-title":"Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?","volume":"1876","author":"Kurma","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0215","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-019-13139-9","article-title":"A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension","volume":"10","author":"Arnold","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bbcan.2023.189004_bb0220","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.bbcan.2023.189004_bb0225","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0230","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2353\/ajpath.2008.070395","article-title":"Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension","volume":"172","author":"Lawrie","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.bbcan.2023.189004_bb0235","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1177\/0961203319867129","article-title":"Serum RANKL, osteoprotegerin (OPG) and RANKL\/OPG ratio in children with systemic lupus erythematosus","volume":"28","author":"Ali","year":"2019","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.bbcan.2023.189004_bb0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-005-2419-8","article-title":"Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?","volume":"92","author":"Holen","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2023.189004_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1476-4598-8-49","article-title":"Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact","volume":"8","author":"Reid","year":"2009","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2023.189004_bb0250","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.4049\/jimmunol.156.12.4622","article-title":"An N-terminal domain shared by Fas\/Apo-1 (CD95) soluble variants prevents cell death in vitro","volume":"156","author":"Papoff","year":"1996","journal-title":"J. Immunol."},{"issue":"5475","key":"10.1016\/j.bbcan.2023.189004_bb0255","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1126\/science.288.5475.2351","article-title":"A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling","volume":"288","author":"Chan","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.22","article-title":"Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling","volume":"8","author":"Smulski","year":"2017","journal-title":"Cell Death Dis."},{"issue":"6633","key":"10.1016\/j.bbcan.2023.189004_bb0265","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2023.189004_bb0270","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1189\/jlb.2MR0215-055R","article-title":"Lipid raft-mediated Fas\/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications","volume":"98","author":"Gajate","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"15","key":"10.1016\/j.bbcan.2023.189004_bb0275","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.onc.1204264","article-title":"Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells","volume":"20","author":"Shao","year":"2001","journal-title":"Oncogene"},{"issue":"35","key":"10.1016\/j.bbcan.2023.189004_bb0280","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1038\/sj.onc.1206540","article-title":"Ceramide-mediated clustering is required for CD95-DISC formation","volume":"22","author":"Grassme","year":"2003","journal-title":"Oncogene"},{"issue":"28","key":"10.1016\/j.bbcan.2023.189004_bb0285","doi-asserted-by":"crossref","first-page":"24026","DOI":"10.1074\/jbc.M111.328211","article-title":"Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts","volume":"287","author":"Lang","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.emboj.7601456","article-title":"Palmitoylation is required for efficient Fas cell death signaling","volume":"26","author":"Chakrabandhu","year":"2007","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0295","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ni1024","article-title":"Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death","volume":"5","author":"Muppidi","year":"2004","journal-title":"Nat. Immunol."},{"issue":"13","key":"10.1016\/j.bbcan.2023.189004_bb0300","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1182\/blood.V98.13.3860","article-title":"The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas\/CD95 into membrane rafts in human leukemic cells","volume":"98","author":"Gajate","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bbcan.2023.189004_bb0305","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20040213","article-title":"Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis","volume":"200","author":"Gajate","year":"2004","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2023.189004_bb0310","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z","article-title":"Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis","volume":"85","author":"Gajate","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0315","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.bbcan.2023.189004_bb0320","doi-asserted-by":"crossref","first-page":"15610","DOI":"10.18632\/oncotarget.14779","article-title":"Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer","volume":"8","author":"Blok","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bbcan.2023.189004_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103348","article-title":"CD95\/Fas protects triple negative breast cancer from anti-tumor activity of NK cells","volume":"24","author":"Qadir","year":"2021","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0330","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cell.2015.03.001","article-title":"KPC1-mediated ubiquitination and proteasomal processing of NF-kappaB1 p105 to p50 restricts tumor growth","volume":"161","author":"Kravtsova-Ivantsiv","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0335","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11060-022-04137-x","article-title":"CRISPR\/Cas9-mediated abrogation of CD95L\/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models","volume":"160","author":"Quijano-Rubio","year":"2022","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0340","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41420-022-01133-y","article-title":"CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner","volume":"8","author":"Quijano-Rubio","year":"2022","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2023.189004_bb0345","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.cell.2019.02.001","article-title":"Higher-order clustering of the transmembrane anchor of DR5 drives signaling","volume":"176","author":"Pan","year":"2019","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.bbcan.2023.189004_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110583","article-title":"Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells","volume":"38","author":"Smulski","year":"2022","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2023.189004_bb0355","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.str.2016.09.009","article-title":"Crystal structure of the complex of human FasL and its decoy receptor DcR3","volume":"24","author":"Liu","year":"2016","journal-title":"Structure"},{"issue":"6","key":"10.1016\/j.bbcan.2023.189004_bb0360","first-page":"2759","article-title":"Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis","volume":"61","author":"Roth","year":"2001","journal-title":"Cancer Res."},{"issue":"5309","key":"10.1016\/j.bbcan.2023.189004_bb0365","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.276.5309.111","article-title":"The receptor for the cytotoxic ligand TRAIL","volume":"276","author":"Pan","year":"1997","journal-title":"Science"},{"issue":"41","key":"10.1016\/j.bbcan.2023.189004_bb0370","doi-asserted-by":"crossref","first-page":"25417","DOI":"10.1074\/jbc.272.41.25417","article-title":"Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL","volume":"272","author":"MacFarlane","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"5327","key":"10.1016\/j.bbcan.2023.189004_bb0375","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2023.189004_bb0380","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48840","article-title":"Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5\/TRAIL-R2","volume":"10","author":"Jeong","year":"2021","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.bbcan.2023.189004_bb0385","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/MCB.23.4.1428-1440.2003","article-title":"Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex","volume":"23","author":"Holler","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.189004_bb0390","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbrc.2004.07.046","article-title":"The secretable form of trimeric TRAIL, a potent inducer of apoptosis","volume":"321","author":"Kim","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2023.189004_bb0395","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2020.08.010","article-title":"Molecular mechanisms of FasL-mediated \u2018reverse-signaling\u2019","volume":"127","author":"Malarkannan","year":"2020","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.bbcan.2023.189004_bb0400","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.cdd.4401305","article-title":"CD95 ligand--death factor and costimulatory molecule?","volume":"10","author":"Janssen","year":"2003","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189004_bb0405","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1182\/blood-2010-07-292722","article-title":"Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain","volume":"117","author":"Luckerath","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bbcan.2023.189004_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2010.62","article-title":"Palmitoylation of human FasL modulates its cell death-inducing function","volume":"1","author":"Guardiola-Serrano","year":"2010","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2023.189004_bb0415","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2007.04.031","article-title":"The CD95 receptor: apoptosis revisited","volume":"129","author":"Peter","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0420","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.187.1.123","article-title":"Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand","volume":"187","author":"Suzuki","year":"1998","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2023.189004_bb0425","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00018-011-0866-4","article-title":"CD95-mediated cell signaling in cancer: mutations and post-translational modulations","volume":"69","author":"Tauzin","year":"2012","journal-title":"Cell. Mol. Life Sci.\u202f: CMLS"},{"key":"10.1016\/j.bbcan.2023.189004_bb0430","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29702","article-title":"Many si\/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism","volume":"6","author":"Putzbach","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.bbcan.2023.189004_bb0435","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.celrep.2014.02.035","article-title":"Death induced by CD95 or CD95 ligand elimination","volume":"7","author":"Hadji","year":"2014","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0440","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BST20211187","article-title":"CD95\/Fas ligand induced toxicity","volume":"51","author":"Haluck-Kangas","year":"2023","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189004_bb0445","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.181.1.71","article-title":"Fas ligand mediates activation-induced cell death in human T lymphocytes","volume":"181","author":"Alderson","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2023.189004_bb0450","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44245","article-title":"The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets","volume":"8","author":"Koike","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.bbcan.2023.189004_bb0455","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.12688\/f1000research.11545.1","article-title":"Autoimmune lymphoproliferative syndrome: more than a FAScinating disease","volume":"6","author":"Bride","year":"2017","journal-title":"F1000Res"},{"issue":"5","key":"10.1016\/j.bbcan.2023.189004_bb0460","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jaci.2022.11.028","article-title":"Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations","volume":"151","author":"Maccari","year":"2023","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X23001531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X23001531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T04:30:26Z","timestamp":1719894626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X23001531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0304419X23001531"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2023.189004","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2023.189004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"189004"}}